Drug intelligence / Profile preview

Morella cerifera pollen

Development stage
Unknown
Lead developer
ALK Abelló
Modality
Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Intradermal, Percutaneous, Subcutaneous
01

Overview

Morella cerifera pollen, also known as Myrica cerifera pollen or southern bayberry, is an allergenic extract derived from the pollen of the Morella cerifera plant. [3, 4] It is a biologic product approved in the United States in 1965 and is used for diagnostic purposes in allergy testing. [3] Administered as an intradermal injection, it helps to establish the clinical relevance of specific allergens by inducing a localized allergic reaction (wheal and flare) in sensitized individuals. [1] This product is intended for diagnostic skin testing only and is not used for therapeutic treatment. [1, 2] It is distributed by companies such as ALK-Abello, Inc. as a non-standardized allergenic extract.

Other names
Myrica cerifera pollenbayberry wax myrtlesouthern bayberry pollenWax Myrtle pollen
02

Targets

MHC II (Major histocompatibility complex class II receptor)

Beyond the preview

Go deeper on Morella cerifera pollen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Morella cerifera pollen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call